AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Reyglim-M4 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sanrey Therapeutics

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Reyglim-M4 Tablet SR

Diabex Duo SR tablets are a dual-action antidiabetic medication, formulated for adult management of type 2 diabetes. This combination therapy effectively regulates blood glucose. Diabex Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is just one element of a comprehensive diabetes management plan; a healthy diet, regular physical activity, and weight management, as directed by your doctor, are essential. Your lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose (e.g., sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Reyglim-M4 Tablet SR

Managing type 2 diabetes

Major Benefits of Reyglim-M4 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Reyglim-M4 Tablet SR with a meal.

Common Side effects of Reyglim-M4 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Reyglim-M4 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Reyglim-M4 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Reyglim-M4 Tablet SR works:

Reyglim-M4 SR tablets contain a dual-action antidiabetic formula: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Reyglim-M4 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Reyglim-M4 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Reyglim-M4 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Reyglim-M4 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Reyglim-M4 SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Reyglim-M4 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A reduced starting dose is usually prescribed for those with mild to moderate liver disease; the medication is unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Reyglim-M4 Tablet SR :

Should you forget a dose of Reyglim-M4 Tablet SR, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Reyglim-M4 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Reyglim-M4 Tablet SR

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Reyglim-M4 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Reyglim-M4 Tablet SR and seek immediate medical attention.
Reyglim-M4 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Reyglim-M4 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Reyglim-M4 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Reyglim-M4 SR tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Reyglim-M4 Tablet SR and alcohol is unsafe. Alcohol can exacerbate Reyglim-M4's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Reyglim-M4 Tablet SR
95
MRP 116
18% off